147 related articles for article (PubMed ID: 31664047)
1. Uremic serum residue decreases SN-38 sensitivity through suppression of organic anion transporter polypeptide 2B1 in LS-180 colon cancer cells.
Ozawa S; Tsujimoto M; Uchiyama H; Ito N; Morishita S; Yamamoto M; Irie R; Sakashita T; Tachiki H; Furukubo T; Izumi S; Yamakawa T; Minegaki T; Nishiguchi K
Sci Rep; 2019 Oct; 9(1):15464. PubMed ID: 31664047
[TBL] [Abstract][Full Text] [Related]
2. Acceleration of carboxylesterase-mediated activation of irinotecan to SN-38 by serum from patients with end-stage kidney disease.
Koide H; Tsujimoto M; Katsube Y; Ochiai M; Hojo A; Furukubo T; Izumi S; Yamakawa T; Shima D; Minegaki T; Nishiguchi K
Cancer Chemother Pharmacol; 2018 Jun; 81(6):1121-1128. PubMed ID: 29693202
[TBL] [Abstract][Full Text] [Related]
3. Cooperative inhibitory effects of uremic toxins and other serum components on OATP1B1-mediated transport of SN-38.
Katsube Y; Tsujimoto M; Koide H; Ochiai M; Hojyo A; Ogawa K; Kambara K; Torii N; Shima D; Furukubo T; Izumi S; Yamakawa T; Minegaki T; Nishiguchi K
Cancer Chemother Pharmacol; 2017 Apr; 79(4):783-789. PubMed ID: 28314987
[TBL] [Abstract][Full Text] [Related]
4. Roles of breast cancer resistance protein and organic anion transporting polypeptide 2B1 in gastrointestinal toxicity induced by SN-38 under inflammatory conditions.
Gulnaz A; Lee KR; Kang MJ; Chang JE; Chae YJ
Toxicol Lett; 2024 Apr; 394():57-65. PubMed ID: 38423481
[TBL] [Abstract][Full Text] [Related]
5. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.
Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N
J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Investigation of Irinotecan Metabolism, Transport, and Gut Microbiome Activation.
Parvez MM; Basit A; Jariwala PB; Gáborik Z; Kis E; Heyward S; Redinbo MR; Prasad B
Drug Metab Dispos; 2021 Aug; 49(8):683-693. PubMed ID: 34074730
[TBL] [Abstract][Full Text] [Related]
7. Pazopanib interacts with irinotecan by inhibiting UGT1A1-mediated glucuronidation, but not OATP1B1-mediated hepatic uptake, of an active metabolite SN-38.
Iwase M; Fujita KI; Nishimura Y; Seba N; Masuo Y; Ishida H; Kato Y; Kiuchi Y
Cancer Chemother Pharmacol; 2019 May; 83(5):993-998. PubMed ID: 30810774
[TBL] [Abstract][Full Text] [Related]
8. Minimal contribution of the hepatic uptake transporter OATP1B1 to the inter-individual variability in SN-38 pharmacokinetics in cancer patients without severe renal failure.
Tsuboya A; Kubota Y; Ishida H; Ohkuma R; Ishiguro T; Hirasawa Y; Ariizumi H; Tsunoda T; Sasaki Y; Matsumoto N; Kondo Y; Tomoda Y; Kusuhara H; Fujita KI
Cancer Chemother Pharmacol; 2021 Sep; 88(3):543-553. PubMed ID: 34117512
[TBL] [Abstract][Full Text] [Related]
9. Interactions between crude drug extracts used in Japanese traditional Kampo medicines and organic anion-transporting polypeptide 2B1.
Iijima R; Watanabe T; Ishiuchi K; Matsumoto T; Watanabe J; Makino T
J Ethnopharmacol; 2018 Mar; 214():153-159. PubMed ID: 29248449
[TBL] [Abstract][Full Text] [Related]
10. Organic anion-transporting polypeptide (OATP) 2B1 contributes to the cellular uptake of theaflavin.
Kondo A; Narumi K; Ogura J; Sasaki A; Yabe K; Kobayashi T; Furugen A; Kobayashi M; Iseki K
Drug Metab Pharmacokinet; 2017 Apr; 32(2):145-150. PubMed ID: 28190756
[TBL] [Abstract][Full Text] [Related]
11. Effects of Uremic Serum Residue on OATP1B1- and OATP1B3-Mediated Pravastatin Uptake in OATP-Expressing HEK293 Cells and Human Hepatocytes.
Uchiyama H; Tsujimoto M; Kimura A; Yuki E; Saiki T; Yoshida T; Furukubo T; Izumi S; Yamakawa T; Tachiki H; Minegaki T; Nishiguchi K
Ther Apher Dial; 2019 Apr; 23(2):126-132. PubMed ID: 30318712
[TBL] [Abstract][Full Text] [Related]
12. Identification of natural products as modulators of OATP2B1 using LC-MS/MS to quantify OATP-mediated uptake.
Wen F; Shi M; Bian J; Zhang H; Gui C
Pharm Biol; 2016; 54(2):293-302. PubMed ID: 25858254
[TBL] [Abstract][Full Text] [Related]
13. Influence of serum in hemodialysis patients on the expression of intestinal and hepatic transporters for the excretion of pravastatin.
Tsujimoto M; Hatozaki D; Shima D; Yokota H; Furukubo T; Izumi S; Yamakawa T; Minegaki T; Nishiguchi K
Ther Apher Dial; 2012 Dec; 16(6):580-7. PubMed ID: 23190519
[TBL] [Abstract][Full Text] [Related]
14. Thyroid Hormones Are Transport Substrates and Transcriptional Regulators of Organic Anion Transporting Polypeptide 2B1.
Meyer Zu Schwabedissen HE; Ferreira C; Schaefer AM; Oufir M; Seibert I; Hamburger M; Tirona RG
Mol Pharmacol; 2018 Jul; 94(1):700-712. PubMed ID: 29735582
[TBL] [Abstract][Full Text] [Related]
15. Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier.
Deguchi T; Isozaki K; Yousuke K; Terasaki T; Otagiri M
J Neurochem; 2006 Feb; 96(4):1051-9. PubMed ID: 16445853
[TBL] [Abstract][Full Text] [Related]
16. Baicalin is a substrate of OATP2B1 and OATP1B3.
Kalapos-Kovács B; Juhász V; Temesszentandrási-Ambrus C; Magda B; Szabó PT; Antal I; Klebovich I; Krajcsi P
Phytother Res; 2018 Aug; 32(8):1647-1650. PubMed ID: 29672961
[TBL] [Abstract][Full Text] [Related]
17. Functional differences in steroid sulfate uptake of organic anion transporter 4 (OAT4) and organic anion transporting polypeptide 2B1 (OATP2B1) in human placenta.
Ugele B; Bahn A; Rex-Haffner M
J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):1-6. PubMed ID: 18501590
[TBL] [Abstract][Full Text] [Related]
18. PLX038: a PEGylated prodrug of SN-38 independent of UGT1A1 activity.
Fontaine SD; Santi AD; Reid R; Smith PC; Ashley GW; Santi DV
Cancer Chemother Pharmacol; 2020 Jan; 85(1):225-229. PubMed ID: 31707444
[TBL] [Abstract][Full Text] [Related]
19. Quercetin-3-rhamnoglucoside (rutin) stimulates transport of organic anion compounds mediated by organic anion transporting polypeptide 2B1.
Ogura J; Koizumi T; Segawa M; Yabe K; Kuwayama K; Sasaki S; Kaneko C; Tsujimoto T; Kobayashi M; Yamaguchi H; Iseki K
Biopharm Drug Dispos; 2014 Apr; 35(3):173-82. PubMed ID: 24285294
[TBL] [Abstract][Full Text] [Related]
20. Pharmacometabolomics Reveals Irinotecan Mechanism of Action in Cancer Patients.
Bao X; Wu J; Kim S; LoRusso P; Li J
J Clin Pharmacol; 2019 Jan; 59(1):20-34. PubMed ID: 30052267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
